Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026)
Cerus' (CERS) quarterly Liabilities and Shareholders Equity came in at $205.2 million in Q2 2026, down 3.7% year-over-year from $213.1 million in Q2 2025, and down 7.95% quarter-over-quarter from $222.9 million in Q1 2026.
Analysis
Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Cerus has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $205.2 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 3.7% year-over-year to $205.2 million; the TTM figure through Jun 2026 stood at $865.1 million (up 6.77% YoY), while the FY2025 annual figure was $221.9 million, up 10.42% from the prior year.
- Liabilities and Shareholders Equity came in at $205.2 million for Q2 2026 at Cerus, down from $222.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $222.9 million in Q1 2026 to a low of $185.5 million in Q2 2024.
- Average Liabilities and Shareholders Equity over 5 years is $207.4 million, with a median of $208.1 million recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity slipped 9.65% in 2024 and climbed 14.87% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $218.1 million in 2022, then retreated by 9.33% to $197.7 million in 2023, then advanced by 1.6% to $200.9 million in 2024, then rose by 10.42% to $221.9 million in 2025, then declined by 7.51% to $205.2 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $205.2 million in Q2 2026, $222.9 million in Q1 2026, and $221.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Cerus | 521.95 Mn | 466.38 Mn | 29.53 Mn | 205.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205.19 Mn |
| Mar 31, 2026 | 222.91 Mn |
| Dec 31, 2025 | 221.86 Mn |
| Sep 30, 2025 | 215.19 Mn |
| Jun 30, 2025 | 213.07 Mn |
| Mar 31, 2025 | 206.78 Mn |
| Dec 31, 2024 | 200.92 Mn |
| Sep 30, 2024 | 189.54 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 189.14 Mn |
| Dec 31, 2023 | 197.75 Mn |
| Sep 30, 2023 | 205.84 Mn |
| Jun 30, 2023 | 198.86 Mn |
| Mar 31, 2023 | 209.34 Mn |
| Dec 31, 2022 | 218.09 Mn |
| Sep 30, 2022 | 215.40 Mn |
| Jun 30, 2022 | 216.46 Mn |
| Mar 31, 2022 | 221.91 Mn |
| Dec 31, 2021 | 237.50 Mn |
| Sep 30, 2021 | 218.95 Mn |